Essays

by Mr Mfazo Hove

Collected longer pieces by Mr Mfazo Hove, reflecting on what he sees in theatres, clinics and health systems every day.

The Future of Eye Care Isn’t Another Clinic, It’s an Ecosystem

Eye care today is delivered in fragments, and that fragmentation carries a genuine clinical cost. Mr Mfazo Hove sets out a different model: one patient, one record, one organisation, with technology connecting screening, monitoring and surgery across a lifetime. Read how continuity could reshape the way you look after your sight.

Better, Safer, and Paid Less

Cataract surgery has never been safer, yet payment for it keeps falling. Consultant ophthalmic surgeon Mr Mfazo Hove explains what modern surgery genuinely costs to deliver, why premium never means a two-tier standard of care, and how expectations of instant perfection now shape recovery. Read the full argument.

What the World Cup and a Packed Cinema Taught Me About the Future of Eye Care

A packed cinema and a World Cup final prompted an unexpected question about eye care. Should patients really change provider every time their vision needs change? Mr Mfazo Hove explores how UK eye care is funded, why lifelong monitoring matters, and what a genuinely continuous relationship could look like. Read on.

What France vs Norway Can Teach Us About Vision, Performance and Eye Health

The best players in the world see the game a fraction of a second before anyone else. That edge is not a gift, it is a measurable sense, and the same visual functions that let a forward time a run are the ones we all rely on to judge a kerb, drive at night or read a menu. As France meet Norway in Boston, Blue Fin Vision® looks at what elite sport reveals about how we really see, and why protecting the full range of vision matters far beyond the pitch.

Beyond the Lectures: The Real Value of International Ophthalmology Meetings

When people picture an international ophthalmology meeting, they picture the lecture programme, the podium, the slides, the data. Those presentations matter. But after speaking at meetings across Europe, I have come to believe that the greatest value usually lies somewhere less obvious.

China Has Solved Scale. The West Has Not.

A week across China's largest eye hospitals revealed a system operating at a scale the West has not yet matched. In this reflection, Mr Mfazo Hove, founder of Blue Fin Vision®, explores what Chinese ophthalmology gets right on volume, where UK consultant-led precision still leads, and why the future of eye care will be built at the intersection of scale and precision.

China Is Solving Presbyopia at Scale – The Rest of Us Are Not Ready

In April 2026, Mr Mfazo Hove was invited as UK faculty at the HORIZON 2026 ZEISS APAC Ophthalmology Symposium and the Bridging Horizons UK-China Summit in Shanghai. Across three cities and five venues, he translated consultant-led UK presbyopia frameworks for delivery at Chinese scale, and returned with lessons that matter for UK refractive surgery now.

What China’s High-Volume Cataract Centres Reveal About Surgical Standards, and What It Means for Patients in the UK

Mr Mfazo Hove, Consultant Ophthalmic Surgeon and Founder of Blue Fin Vision®, has been invited to collaborate with leading ophthalmic centres in China to discuss modern cataract surgery, trifocal lens technology, and patient outcomes. This post explains what prompted that invitation, what the collaboration involves, and, most importantly, what patients in the United Kingdom can take from it.

When Success Triggers Hate: A Surgeon’s Reflection on Racism, Recognition and Resilience

There are milestones in one’s professional life that should be simple moments of pride.

The Hidden Problem: Why Evidence-Based Excellence Goes Unseen in Healthcare

In an age where countless clinics advertise themselves as "the best", patients face a bewildering challenge: how do you separate genuine excellence from clever marketing?

Appetite for Change: How Weight Loss Drugs Are Redefining Private Healthcare in the UK

In a healthcare system long defined by “one-off” interventions – hip replacements, cataract surgeries, or laser vision correction – a quiet revolution is taking place. Weight loss medications like Ozempic® (semaglutide) and Mounjaro® (tirzepatide) are not just shifting waistlines. They are shifting the very model of private healthcare in the UK.